Making cold malignant pleural effusions hot: driving novel immunotherapies.
作者： Pranav Murthy , Chigozirim N. Ekeke , Kira L. Russell , Samuel C. Butler , Yue Wang
DOI: 10.1080/2162402X.2018.1554969
关键词: Oncology 、 Internal medicine 、 Poor prognosis 、 Medicine 、 Advanced disease 、 non-small cell lung cancer (NSCLC)
摘要: Malignant pleural effusions, arising from either primary mesotheliomas or secondary malignancies, heralds advanced disease and poor prognosis. Current treatments, including therapeutic thoracentesi...
sci-hub.se 参考文章(268)
Fran Balkwill, Alberto Mantovani, Inflammation and cancer: back to Virchow? The Lancet. ,vol. 357, pp. 539- 545 ,(2001) , 10.1016/S0140-6736(00)04046-0
Ira Mellman, Dendritic Cells: Master Regulators of the Immune Response Cancer immunology research. ,vol. 1, pp. 145- 149 ,(2013) , 10.1158/2326-6066.CIR-13-0102
Douglas Hanahan, Robert A. Weinberg, Hallmarks of cancer: the next generation. Cell. ,vol. 144, pp. 646- 674 ,(2011) , 10.1016/J.CELL.2011.02.013
Xue-Jun Qin, Huan-Zhong Shi, Jing-Min Deng, Qiu-Li Liang, Jing Jiang, Zhi-Jian Ye, CCL22 Recruits CD4-positive CD25-positive Regulatory T Cells into Malignant Pleural Effusion Clinical Cancer Research. ,vol. 15, pp. 2231- 2237 ,(2009) , 10.1158/1078-0432.CCR-08-2641
Amelia O Clive, Brennan C Kahan, Clare E Hooper, Rahul Bhatnagar, Anna J Morley, Natalie Zahan-Evans, Oliver J Bintcliffe, Rogier C Boshuizen, Edward TH Fysh, Claire L Tobin, Andrew RL Medford, John E Harvey, Michel M van den Heuvel, YC Gary Lee, Nick A Maskell, None, Predicting survival in malignant pleural effusion: development and validation of the LENT prognostic score Thorax. ,vol. 69, pp. 1098- 1104 ,(2014) , 10.1136/THORAXJNL-2014-205285
C. Cao, S. K. Krog Andvik, T. D. Yan, C. Kennedy, P. G. Bannon, B. C. McCaughan, Staging of patients after extrapleural pneumonectomy for malignant pleural mesothelioma--institutional review and current update. Interactive Cardiovascular and Thoracic Surgery. ,vol. 12, pp. 754- 757 ,(2011) , 10.1510/ICVTS.2010.262972
Evemie Schutyser, Ann Richmond, Jo Van Damme, Involvement of CC chemokine ligand 18 (CCL18) in normal and pathological processes. Journal of Leukocyte Biology. ,vol. 78, pp. 14- 26 ,(2005) , 10.1189/JLB.1204712
Creg J. Workman, Linda S. Cauley, In-Jeong Kim, Marcia A. Blackman, David L. Woodland, Dario A. A. Vignali, Lymphocyte Activation Gene-3 (CD223) Regulates the Size of the Expanding T Cell Population Following Antigen Activation In Vivo Journal of Immunology. ,vol. 172, pp. 5450- 5455 ,(2004) , 10.4049/JIMMUNOL.172.9.5450
Antonio Di Stasi, Siok-Keen Tey, Gianpietro Dotti, Yuriko Fujita, Alana Kennedy-Nasser, Caridad Martinez, Karin Straathof, Enli Liu, April G. Durett, Bambi Grilley, Hao Liu, Conrad R. Cruz, Barbara Savoldo, Adrian P. Gee, John Schindler, Robert A. Krance, Helen E. Heslop, David M. Spencer, Cliona M. Rooney, Malcolm K. Brenner, Inducible apoptosis as a safety switch for adoptive cell therapy The New England Journal of Medicine. ,vol. 365, pp. 1673- 1683 ,(2011) , 10.1056/NEJMOA1106152
Daniel S. Chen, Bryan A. Irving, F. Stephen Hodi, Molecular Pathways: Next-Generation Immunotherapy—Inhibiting Programmed Death-Ligand 1 and Programmed Death-1 Clinical Cancer Research. ,vol. 18, pp. 6580- 6587 ,(2012) , 10.1158/1078-0432.CCR-12-1362